Evidence |
1. Background information |
1-8 |
|
2. Opioid and benzodiazepine prescribing practices |
9-13 |
|
3. Knowledge of pain management and insomnia clinical practice guidelines |
14-15 |
|
4. Level of agreement with clinical practice guidelines that caution against concurrent prescribing of opioids and benzodiazepines among high risk groups |
16 |
|
5. Beliefs that contribute to opioid and benzodiazepine co-prescribing |
17-18 |
|
6. Beliefs about discontinuing co-prescribed opioids and benzodiazepines |
19-20 |
|
7. Typical outcomes for patients co-prescribed opioids and benzodiazepines |
21-25 |
Context |
8. Team support/encouragement around reducing opioid and benzodiazepine co-prescribing |
26 |
|
9. Resources that would support efforts to discontinue or reduce co-prescribing of opioids and benzodiazepines |
27-29 |
|
10. Potential benefits of and barriers to using medication alerts |
30 |